MONOKLONALE MARBURG-ANTIKÖRPER

Patent europeic · EP3145546 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP3145546
Numer da la dumonda
EP15752115
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
19-02-2015
Publitgà
29-03-2017
Concedì
09-12-2020
Stritgà
28-02-2021
Motiv
Taxa annuala betg pajada
Classas IPC
A61K 39/42 (2006.01)
C07K 16/10 (2006.01)
Prioritad
US 201461941807 P 19.02.2014
US 201462016419 P 24.06.2014
Dumonda PCT
PCT/US2015/016708 19.02.2015
Publicaziun PCT
WO2015/127140 27.08.2015
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 27-10-2021

    Midada

    Published in Swissreg on 27.10.2021

  2. 22-09-2021

    Stritgà, taxa betg pajada

    Published in Swissreg on 22.09.2021

  3. 09-12-2020

    Concedì

    Published in Swissreg on 09.12.2020

Partidas

Possessur

Emergent BioSolutions Canada Inc.

1 First Canadian Place, Suite 3400, Toronto, Ontario M5X 1A4, CA

The Scripps Research Institute

10550 North Torrey Pines Road, La Jolla, CA 92037, US

Inventur

Saphire, Erica

La Jolla, California 92037, US

Berry, Jody

Winnipeg, Manitoba R3T 5Y3, CA

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.